nodepositbonusroulette| Lilly adds "slimming drugs": announced an investment of US$5.3 billion to expand production capacity

Lilly adds "slimming drugs": announced an investment of US$5.3 billion to expand production capacity

Source: Zhao Ying from Wall Street

This is the largest investment in the company's nearly 150-year history.

According to media reports on FridaynodepositbonusrouletteLilly has made a major decision to announce that it will invest $5.3 billion to increase the production capacity of tirzepatide, a key ingredient in its weight loss and diabetes injections.

This investment not only adds to existing plans, but is also the largest investment in the company's nearly 150-year history.

This will expand its manufacturing facility in Indiana, which makes tirzepatide, the active ingredient of Zepbound diet drug and diabetes blockbuster Mounjaro.

Tags:

Prev: luckyspinslots| Changes in U.S. stocks | Caijie plunged more than 9% to a new low in more than one month. The Q4 performance guidance fell short of expectations, and Bank of America lowered its target price
Next: progressiveslots| U.S. semiconductor stocks collectively rose: TSMC and Nvidia rose more than 1%